Oct 1, 1989

A case of refractory testicular cancer showing complete response to high-dose chemotherapy with autologous bone marrow transplantation

Gan to kagaku ryoho. Cancer & chemotherapy
H IshiiS Asano

Abstract

A patient with stage III testicular cancer was treated by 3 courses of BEP therapy and a partial response was obtained. Afterwards he underwent resection of pulmonary residual tumors and was treated by 2 courses of PE therapy immediately after operation. However, a new pulmonary tumor appeared after the first course of PE therapy was completed. He was treated by high-dose chemotherapy (etoposide 1200 mg/m2, cyclophosphamide 120 mg/kg, CDDP 60 mg/m2) with autologous bone marrow transplantation. Three weeks after high-dose chemotherapy his metastatic pulmonary tumor showed cavity formation which disappeared after 3 months. Fifteen months after the high-dose chemotherapy, no evidence of disease has been seen even without maintenance therapy.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

PVP16P
Gastroschisis
Antineoplastic Chemotherapy Protocols
Mature Teratoma
Combined Modality Therapy
Testicular Neoplasms
Remission Induction
Transplantation, Autologous
Drug Resistance
Bone Marrow Cell Transplantation

About this Paper

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.